Golden Gate Private Equity’s Medifast MED Stock Holding History

Golden Gate Private Equity’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-472,205	Closed	-$14.2M	–	11
2015 Q1	$14.2M	Hold	472,205	–	–	3.78%	4
2014 Q4	$15.8M	Hold	472,205	–	–	4.83%	4
2014 Q3	$15.5M	Hold	472,205	–	–	4.37%	4
2014 Q2	$14.4M	Hold	472,205	–	–	2.9%	4
2014 Q1	$13.7M	Sell	472,205 -1,600	-0.3%	-$42.9K	3.07%	4
2013 Q4	$12.4M	Buy	+473,805	New	+$12.1M	5.26%	5

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Golden Gate Private Equity's MED Position: Q2 2015 in Review

Golden Gate Private Equity sold out of Medifast (MED) in Q2 2015, closing a stake of 472,205 shares — an estimated $14.2M sold.

Golden Gate Private Equity first reported a position in MED in Q4 2013 and held it in 6 quarters. The position peaked at $15.8M in Q4 2014. 129 funds tracked by Wall St. Rank hold MED as of Q2 2015.

Golden Gate Private Equity reported no remaining Medifast position as of Q2 2015 after selling out during the quarter.
Golden Gate Private Equity sold 472,205 Medifast shares in Q2 2015, an estimated $14.2M.
Golden Gate Private Equity first reported a position in Medifast in Q4 2013 and held it in 6 quarters.
Golden Gate Private Equity's Medifast position peaked at $15.8M in Q4 2014.
129 funds tracked by Wall St. Rank held Medifast as of Q2 2015.

Based on Golden Gate Private Equity's 13F filing for Q2 2015, filed 14 Aug 2015.